Rosuvastatīns - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

rosuvastatin teva pharma 40 mg film-coated tablets

teva b.v. - rosuvastatin - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; rosuvastatin - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular even

Ireland - English - HPRA (Health Products Regulatory Authority)

rosuvastatin teva pharma 5 mg film-coated tablets

teva b.v. - rosuvastatin - film-coated tablet - 5 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

rosuvastatin teva pharma 10 mg film-coated tablets

teva b.v. - rosuvastatin - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; rosuvastatin

Ireland - English - HPRA (Health Products Regulatory Authority)

rosuvastatin teva pharma 20 mg film-coated tablets

teva b.v. - rosuvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; rosuvastatin